ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium
Garching / Munich, Germany, June 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will provide further analysis from its recently completed Phase 3 COMPETE trial in an oral presentation and Satellite Symposium at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, held from June 21 – June 24, 2025 in New Orleans, Louisiana. Details of the Oral PresentationThe data will be presented by Dr. Thomas A. Hope, MD, Chief of Nuclear Medicine at the San Francisco VA Medical Center and Vice Chair of Clinical Operations and Strategy in the Department of Radiology at UCSF in an oral presentation titled, 'Predicting the [177Lu]Lu-edotreotide uptake in tumors using pre-therapeutic Ga-68 PET/CT imaging', on Sunday, June 22 in the Neuroendocrine - Oncology Clinical Diagnosis and Therapy session from 3:30 – 4:45 pm CDT. The presentation will provide an analysis on the 177Lu-edotreotide tumor uptake and its predictability based on pre-therapeutic SSTR PET/CT imaging and other factors.
Symposium DetailsThe symposium, 'Pursuing the Art and Science of RPT: COMPETE Results and the Evolution of Dosimetry,' will take place on Sunday June 22, from 6:30 pm – 7:30 pm CDT. The symposium will feature an overview of the GEP-NET treatment landscape, including findings from the Phase 3 COMPETE trial, and perspectives on dosimetry standardization today and in the future. COMPETE evaluated n.c.a 177Lu-edotreotide (also known as ITM-11) in patients with grade 1 or grade 2 gastroenteropancreatic neuroendocrine tumors (GEP-NET) and ITM announced the positive Phase 3 results in March 2025.
Date and Time: Sunday, June 22, from 6:30 pm – 7:30 pm CDTLocation: Ernest N. Morial Convention Center, New Orleans, LA; Room R04-R05Speakers and Topics:
GEP-NET treatment landscape, COMPETE trial results, and COMPOSE trial designJonathan Strosberg, MD; Section Head, Neuroendocrine Division Program Chair, Gastrointestinal Department Oncology Research Program Moffitt Cancer Center
COMPETE dosimetry sub-study and the evolution of dosimetryJohn Sunderland, PhD; Professor of Radiology Nuclear Medicine Division University of Iowa
Dr. Celine Wilke Participates in Entrepreneur's PanelAs part of the SNMMI conference, Dr. Celine Wilke, ITM's Chief Medical Officer will participate in the 'Entrepreneur's Panel: Community Based Sites – Accelerating Clinical Trials and Expanding Access,' on Saturday, June 21, from 3:30 – 4:45 pm CDT.ITM will further be present at the conference with a booth (booth number: 1001) providing information on the company's latest innovations in radiopharmaceutical therapy (RPT), its pipeline of RPT therapeutics and the company's capabilities to produce high-quality medical radioisotopes for global partners and its own pipeline.
About the COMPETE TrialThe COMPETE trial evaluated 177Lu-edotreotide (ITM-11), a proprietary, synthetic, targeted radiotherapeutic agent compared to everolimus, a targeted molecular therapy, in patients with inoperable, progressive Grade 1 or Grade 2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This trial met its primary endpoint, with 177Lu-edotreotide demonstrating clinically and statistically significant improvement in progression-free survival (PFS) compared to everolimus. 177Lu-edotreotide is also being evaluated in COMPOSE, a Phase 3 study in patients with well-differentiated, aggressive Grade 2 or Grade 3, SSTR-positive GEP-NET tumors.
About ITM Isotope Technologies Munich SEITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply of medical radioisotopes. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including multiple Phase 3 studies, combining the company's high-quality radioisotopes with a range of targeting molecules. By leveraging our two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life. www.itm-radiopharma.com
ITM ContactCorporate CommunicationsKathleen Noonan/Julia WestermeirPhone: +49 89 329 8986 1500Email: communications@itm-radiopharma.com
Investor RelationsBen OrzelekPhone: +49 89 329 8986 1009Email: investors@itm-radiopharma.com
Attachment
20250613_ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Scientists make jaw-dropping find at base of Antarctic glacier: 'May be greatly underestimated'
Antarctica was once believed to host little biodiversity beyond coastal areas and a few hardy microbes, but a team of scientists has made a shocking discovery beneath a slowly retreating glacier in Antarctica: a bustling network of microbial life. A team of researchers aboard Germany's Polarstern research vessel traveled to the Larsemann Hills on the southern coast of Antarctica to analyze the biodiversity of disturbed soil near the glacier's edge. Their findings, titled "Advocating microbial diversity conservation in Antarctica" and published in Frontiers, revealed 2,829 genetically defined species, and the study revealed associations among these species that suggest that these organisms don't merely coexist; they collaborate to survive. One of the study's authors, Dr. Dirk Wagner, a professor at the GFZ Helmholtz Centre for Geosciences and the University of Potsdam in Germany, said, "Here we reveal unexpectedly abundant and diverse microbial community even in these driest, coldest, and nutrient-poorest of soils, which suggest that biodiversity estimates in Antarctic soils may be greatly underestimated." By analyzing both DNA from living and extinct organisms, researchers revealed a dynamic history of life that now provides science with a better understanding of how ecological succession and symbiotic relationships have transformed Antarctica's hostile environment into a hospitable habitat. One of the study's key discoveries is that these organisms cooperate. Cold-loving fungi could be breaking down organic matter to supply bacteria with carbon. Algae and bacteria appear to exchange nutrients, and different species have settled into unique zones proximal to the glacier. These discoveries suggest that this tightly knit ecological network could be the very thing that makes life hospitable in this harsh region. A study published in March found that conserving diverse microbial ecosystems in Antarctica in the face of the changing climate is crucial, as these organisms thrive in extreme conditions and influence nutrient cycling and carbon sequestration. The authors wrote, "By prioritizing microbial conservation, strengthening international cooperation, and integrating protection plans into policy frameworks, we can safeguard these invaluable ecosystems for future generations." Do you think America is in a housing crisis? Definitely Not sure No way Only in some cities Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
2 hours ago
- Yahoo
Scientists Just Found Something Unbelievably Grim About Pollution Generated by AI
Tech companies are hellbent on pushing out ever more advanced artificial intelligence models — but there appears to be a grim cost to that progress. In a new study in the science journal Frontiers in Communication, German researchers found that large language models (LLM) that provide more accurate answers use exponentially more energy — and hence produce more carbon — than their simpler and lower-performing peers. In other words, the findings are a grim sign of things to come for the environmental impacts of the AI industry: the more accurate a model is, the higher its toll on the climate. "Everyone knows that as you increase model size, typically models become more capable, use more electricity and have more emissions," Allen Institute for AI researcher Jesse Dodge, who didn't work on the German research but has conducted similar analysis of his own, told the New York Times. The team examined 14 open source LLMs — they were unable to access the inner workings of commercial offerings like OpenAI's ChatGPT or Anthropic's Claude — of various sizes and fed them 500 multiple choice questions plus 500 "free-response questions." Crunching the numbers, the researchers found that big, more accurate models such as DeepSeek produce the most carbon compared to chatbots with smaller digital brains. So-called "reasoning" chatbots, which break problems down into steps in their attempts to solve them, also produced markedly more emissions than their simpler brethren. There were occasional LLMs that bucked the trend — Cogito 70B achieved slightly higher accuracy than DeepSeek, but with a modestly smaller carbon footprint, for instance — but the overall pattern was stark: the more reliable an AI's outputs, the greater its environmental harm. "We don't always need the biggest, most heavily trained model, to answer simple questions," Maximilian Dauner, a German doctoral student and lead author of the paper, told the NYT. "Smaller models are also capable of doing specific things well. The goal should be to pick the right model for the right task." That brings up an interesting point: do we really need AI in everything? When you go on Google, those annoying AI summaries pop up, no doubt generating pollution for a result that you never asked for in the first place. Each individual query might not count for much, but when you add them all up, the effects on the climate could be immense. OpenAI CEO Sam Altman, for example, recently enthused that a "significant fraction" of the Earth's total power production should eventually go to AI. More on AI: CEOs Using AI to Terrorize Their Employees
Yahoo
4 hours ago
- Yahoo
Why Volkswagen is convinced Waymo and Tesla are vulnerable in the $500 billion robotaxi race — ‘not a winner take all market'
The German carmaker is preparing to enter the market for autonomous ride-hailing services next year with its Volkswagen ID. Buzz AD. But instead of competing against existing transportation providers, it aims to work with them as a partner. The different approach comes amid continued popular resentment towards robotaxis. When Big Tech first began deploying self-driving cars to San Francisco two years ago, companies encountered something unusual—popular resistance. Angry residents would sabotage the robotaxis with the help of traffic cones, while the city's fire department chief herself would regularly malign them as a dangerous nuisance. Even today, during the recent outbreak of civil unrest in Los Angeles over mass deportations, protesters caused hundreds of thousands of dollars when they deliberately torched Waymo cars. One old economy company preparing to enter the autonomous ride-hailing space is taking a completely different approach when it launches next year. Germany's Volkswagen is wagering society at large is increasingly fed up with the collateral damage left behind by Silicon Valley's move-fast-and-break-things mentality. 'Our approach is different—we deliberately want to act as partners that build upon existing infrastructure,' VW Group executive Sascha Meyer told Fortune during a test drive of its robotaxi. 'A key point for social acceptance we believe is being a service provider whose presence is desired precisely because we will not be competing with systems already in place.' This week, VW revealed the series production version of its autonomous ride-hailing cab based on its retro-styled VW ID. Buzz EV microbus. Packaged together with the requisite fleet management software and digital customer booking platform, it wants to offer local transportation authorities and other commercial fleets a turnkey solution that can be integrated effortlessly into their service. While a Waymo or a Tesla plan to compete with existing providers, the German carmaker aims to be an equal partner working hand in glove with communities that want their help. Even if the first roughly 500 vehicles won't be deployed to Uber for use in Los Angeles until next year, VW believes the race for market share is only just beginning. It's convinced there will be more than enough demand to grab a bite out of the €350 billion-€450 billion in revenue McKinsey projects for autonomous ride-hailing services in North America and Europe by 2035. That's more than half a trillion dollars worth of growth over the next 10 years, potentially. Meyer runs MOIA, the mobility services subsidiary of the VW Group which will offer a high-tech version of the zero-emission Volkswagen ID. Buzz electric minivan complete with the backend software ecosystem around it. Fortune had a chance to ride along with Meyer in one as the robotaxi navigated its way—with a safety driver behind the wheel at all times—through the busy streets of Hamburg. Here in Germany's second-largest city, Volkswagen has quietly been testing the technology for several years now thanks to the active support of city officials. The white label service Volkswagen has in mind means all customers need to do is slap their logo on the vehicle and adorn the customer-facing front end with their respective corporate identity and they are ready to go. The group's go-to-market strategy heavily incorporates public transit authorities, an approach influenced by its European roots. With their extensive wealth of well-built mass transit networks, these mainly state and municipal-owned companies play a role in urban, suburban and ex-urban mobility so crucial it would be difficult to displace them. Take for example the BVG authority operated by the German capital of Berlin, with whom VW Group already has signeda letter of intent. Three million people entrust their everyday transportation needs to its fine meshed web of buses, streetcars, subways and commuter trains to get back and forth in the greater metropolitan area every day. A BVG-branded robotaxi integrated into its service should see far faster adoption than were Volkswagen to compete alongside it. In a way, VW's partnership approach to the market is a natural fit. Carmakers have decades of experience working closely with regulators from various agencies, state and federal, to ensure their cars conform with traffic safety and environmental standards. In Silicon Valley, however, regulators are often viewed with suspicion—at best an irritant, at worst the enemy. The debacle around robotaxi developer Cruise proved that: following a fateful October 2023 accident in San Francisco, the tech startup deliberately withheld crucial information from crash investigators, shattering what trust was placed in them by the state of California only weeks earlier. When Cruise owner General Motors found out, it acted swiftly to sideline the CEO, but by then it was too late and the reputational damage was done. Cruise ceased all operations and GM pulled out of the autonomous ride-hailing race in December. With crosstown rival Ford already giving up even earlier, only Volkswagen and Hyundai, through its Motional subsidiary, still remain in contention from the legacy car industry. The rest are AI tech companies like Waymo, Tesla, Amazon subsidiary Zoox as well as their foreign equivalents like China's Baidu and Wayve in the UK. Of course, Meyer knows that the competition has a head start they won't hand over willingly. 'Waymo has an indisputable lead, that's clear, and I don't believe they're going to slow down in any way,' he told Fortune. Then there's Tesla, which is gearing up to launch its own pilot in Austin due to launch Sunday. While Meyer readily admits it's likely only a matter of time until Tesla can graduate to a full commercial robotaxi service, he believes all is not lost. For one, neither is present in Europe, a market known for being far more risk-averse towards unproven technologies and quick to regulate against threats towards public safety. Tesla's vaunted Full Self-Driving (FSD) feature, a software stack that will imbue its robotaxis with the requisite intelligence, hasn't yet been approved for use anywhere on the continent. In fact, it's not even available as an advanced driver assist. This offers enough of an opportunity for Volkswagen to greenlight the production of at least 10,000 robotaxi vehicles, potentially more. And even if Waymo and Tesla do retain their lead by the time VW is ready, Meyer believes communities will demand some degree of healthy competition among autonomous ride hailing providers in order to ensure an optimum service for a low cost. 'No one, not even in the United States, will be happy if there's a monopoly,' he said. 'We don't believe it will be a winner-takes-all market.' This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
